PALB2 and breast carcinoma: Finally, an analysis of tumours with germline pathogenic variants in six high to moderate breast cancer susceptibility genes did not reveal any significant differences between our cohort and TCGA26, except for a marginally significant higher prevalence in germline PALB2 mutations (Supplementary Table 4).